A Plc who has, just this year, received orders from Eisai and Astrazeneca8 May 2024 13:35
(both top 100 Plc's in their respective Countries) to develop assays (tests) for use during cancer drug trials. Indeed 2 from Astrazeneca (so far). Multi million potential if just one of the 3 cancer trials progress to later stages. Is in discussions with 11 other Companies (at the moment), 2 of them also household names to produce other assays. Once done these assays can also be offered to other Companies.
A market cap of £49m. Some kind of joke, right?
Angle is due a massive re-rating by the market. Massive.
50p a share for starters.
All IMHO.